{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T10:56:14Z","timestamp":1724496974484},"reference-count":79,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Cardiac Failure"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.cardfail.2019.09.008","type":"journal-article","created":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T23:33:54Z","timestamp":1568763234000},"page":"921-931","source":"Crossref","is-referenced-by-count":5,"title":["Interaction Between Sacubitril and Valsartan in Preventing Heart Failure Induced by Aortic Valve Insufficiency in Rats"],"prefix":"10.1016","volume":"25","author":[{"given":"Mikhail Y.","family":"Maslov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan","family":"Foianini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dita","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael V.","family":"Orlov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark A.","family":"Lovich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl","key":"10.1016\/j.cardfail.2019.09.008_bib0001","first-page":"708.3","article-title":"Exercise training intolerance in heart failure with preserved ejection fraction is associated with altered chemoreflex gain and sympathoexcitation in rats","volume":"31","author":"Andrade","year":"2017","journal-title":"FASEB J"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0002","first-page":"128","article-title":"Experimental aortic regurgitation in rats under echocardiographic guidance","volume":"11","author":"Arsenault","year":"2002","journal-title":"J Heart Valve Dis"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0003","doi-asserted-by":"crossref","first-page":"017","DOI":"10.1038\/s41598-017-00855-9","article-title":"Female rats with severe left ventricle volume overload exhibit more cardiac hypertrophy but fewer myocardial transcriptional changes than males","volume":"7","author":"Beaumont","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0004","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1161\/HYPERTENSIONAHA.109.142190","article-title":"Arterial stiffness is regulated by nitric oxide and endothelium-derived hyperpolarizing factor during changes in blood flow in humans","volume":"55","author":"Bellien","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0005","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1472-8206.2008.00610.x","article-title":"Contribution of endothelium-derived hyperpolarizing factors to the regulation of vascular tone in humans","volume":"22","author":"Bellien","year":"2008","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0006","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.ijcard.2017.10.074","article-title":"Sacubitril\/valsartan and short-term changes in the 6-minute walk test: a pilot study","volume":"252","author":"Beltran","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0007","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1093\/eurheartj\/ehw570","article-title":"Systolic blood pressure, cardiovascular outcomes and efficacy and safety of sacubitril\/valsartan (LCZ696) in patients with chronic heart failure and reduced ejection fraction: results from PARADIGM-HF","volume":"38","author":"Bohm","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0008","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1136\/heartjnl-2015-308416","article-title":"Controlled release metoprolol for aortic regurgitation: a randomised clinical trial","volume":"102","author":"Broch","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0009","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.ijcard.2016.08.237","article-title":"Exercise capacity and peak oxygen consumption in asymptomatic patients with chronic aortic regurgitation","volume":"223","author":"Broch","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0010","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nrcardio.2016.200","article-title":"Long-term neprilysin inhibition - implications for ARNIs","volume":"14","author":"Campbell","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0011","first-page":"567","article-title":"Effects of neutral endopeptidase inhibition and combined angiotensin converting enzyme and neutral endopeptidase inhibition on angiotensin and bradykinin peptides in rats","volume":"287","author":"Campbell","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0012","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/S0140-6736(05)77712-6","article-title":"Lack of efficacy of neutral endopeptidase inhibitor ecadotril in heart failure. The International Ecadotril Multi-centre Dose-ranging Study Investigators","volume":"351","author":"Cleland","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0013","unstructured":"Data on File. Novartis Pharmaceuticals Corp; East Hanover, NJ."},{"key":"10.1016\/j.cardfail.2019.09.008_bib0014","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.2337\/db18-0062","article-title":"Vascular and neural complications in type 2 diabetic rats: improvement by sacubitril\/valsartan greater than valsartan alone","volume":"67","author":"Davidson","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0015","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.recesp.2016.12.018","article-title":"Role of myocardial collagen in severe aortic stenosis with preserved ejection fraction and symptoms of heart failure","volume":"70","author":"Echegaray","year":"2017","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0016","doi-asserted-by":"crossref","first-page":"015","DOI":"10.1186\/s40064-015-1317-8","article-title":"Sildenafil treatment attenuates ventricular remodeling in an experimental model of aortic regurgitation","volume":"4","author":"Eskesen","year":"2015","journal-title":"Springerplus"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0017","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/S0735-1097(01)01170-6","article-title":"Activation of the cardiac renin-angiotensin system and increased myocardial collagen expression in human aortic valve disease","volume":"37","author":"Fielitz","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0018","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1007\/s00380-012-0311-0","article-title":"Atrial natriuretic peptide exerts protective action against angiotensin II-induced cardiac remodeling by attenuating inflammation via endothelin-1\/endothelin receptor A cascade","volume":"28","author":"Fujita","year":"2013","journal-title":"Heart Vessels"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0019","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/S0895-7061(97)00311-7","article-title":"Vascular compliance and cardiovascular disease: a risk factor or a marker?","volume":"10","author":"Glasser","year":"1997","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0020","doi-asserted-by":"crossref","first-page":"7580","DOI":"10.1073\/pnas.86.19.7580","article-title":"Protection of atrial natriuretic factor against degradation: diuretic and natriuretic responses after in vivo inhibition of enkephalinase (EC 3.4.24.11) by acetorphan","volume":"86","author":"Gros","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0021","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/0091270009343932","article-title":"Pharmacokinetics and pharmacodynamics of LCZ696, a novel dual-acting angiotensin receptor-neprilysin inhibitor (ARNi)","volume":"50","author":"Gu","year":"2010","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0022","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1177\/0218492316641287","article-title":"Effect of ejection fraction on left ventricular remodeling in aortic insufficiency","volume":"24","author":"Gunay","year":"2016","journal-title":"Asian Cardiovasc Thorac Ann"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0023","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/ejhf.696","article-title":"Myocardial fibrosis: biomedical research from bench to bedside","volume":"19","author":"Gyongyosi","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0024","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3317\/jraas.2003.030","article-title":"Elevated intracardiac angiotensin II leads to cardiac hypertrophy and mechanical dysfunction in normotensive mice","volume":"4","author":"Huggins","year":"2003","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0025","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jacbts.2017.08.001","article-title":"Cardioprotective effects of LCZ696 (sacubitril\/valsartan) after experimental acute myocardial infarction","volume":"2","author":"Ishii","year":"2017","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0026","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1136\/heartjnl-2014-306775","article-title":"The neprilysin pathway in heart failure: a review and guide on the use of sacubitril\/valsartan","volume":"102","author":"Jhund","year":"2016","journal-title":"Heart"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0027","first-page":"5473","article-title":"LCZ696 (Sacubitril\/valsartan) ameliorates oxidative stress, inflammation, fibrosis and improves renal function beyond angiotensin receptor blockade in CKD","volume":"9","author":"Jing","year":"2017","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0028","first-page":"1","article-title":"Short-term evaluation of captopril in patients with chronic left sided valvular regurgitations","volume":"81","author":"Jirasirirojanakorn","year":"1998","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0029","first-page":"24S","article-title":"Interaction between atrial natriuretic peptide and the renin angiotensin aldosterone system. Endogenous antagonists","volume":"87","author":"Johnston","year":"1989","journal-title":"Am J Med"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0030","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1023\/B:MCBI.0000026062.29029.d4","article-title":"AT1 receptor blockade limits myocardial injury and upregulates AT2 receptors during reperfused myocardial infarction","volume":"260","author":"Jugdutt","year":"2004","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0031","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1113\/expphysiol.2014.084095","article-title":"Angiotensin II can directly induce mitochondrial dysfunction, decrease oxidative fibre number and induce atrophy in mouse hindlimb skeletal muscle","volume":"100","author":"Kadoguchi","year":"2015","journal-title":"Exp Physiol"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0032","first-page":"1108","article-title":"Effects of intravenous atrial natriuretic peptide on cardiac sympathetic nerve activity in patients with decompensated congestive heart failure","volume":"45","author":"Kasama","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0033","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.jacc.2010.10.024","article-title":"Diastolic tissue Doppler indexes correlate with the degree of collagen expression and cross-linking in heart failure and normal ejection fraction","volume":"57","author":"Kasner","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0034","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.002423","article-title":"Natriuretic peptides in the regulation of cardiovascular physiology and metabolic events","volume":"4","author":"Kerkela","year":"2015","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0035","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1161\/hy1101.095329","article-title":"Endothelium-derived nitric oxide regulates arterial elasticity in human arteries in vivo","volume":"38","author":"Kinlay","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0036","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S1010-7940(00)00341-9","article-title":"Increased aortic compliance maintains left ventricular performance at lower energetic cost","volume":"17","author":"Kolh","year":"2000","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0037","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ijcard.2018.01.077","article-title":"Angiotensin receptor neprilysin inhibition provides superior cardioprotection compared to angiotensin converting enzyme inhibition after experimental myocardial infarction","volume":"258","author":"Kompa","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0038","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1093\/ajh\/hpv015","article-title":"LCZ696, angiotensin II receptor-neprilysin inhibitor, ameliorates high-salt-induced hypertension and cardiovascular injury more than valsartan alone","volume":"28","author":"Kusaka","year":"2015","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0039","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.116.003430","article-title":"Health-related quality of life outcomes in PARADIGM-HF","volume":"10","author":"Lewis","year":"2017","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0040","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/AC.70.1.3064595","article-title":"Valsartan-induced cardioprotection involves angiotensin II type 2 receptor upregulation in isolated ischaemia and reperfused rat hearts","volume":"70","author":"Li","year":"2015","journal-title":"Acta Cardiol"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0041","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1161\/CIRCRESAHA.107.157677","article-title":"Atrial natriuretic peptide inhibits transforming growth factor beta-induced Smad signaling and myofibroblast transformation in mouse cardiac fibroblasts","volume":"102","author":"Li","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0042","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1358\/mf.2000.22.10.802287","article-title":"Induction of cardiac fibrosis by angiotensin II","volume":"22","author":"Lijnen","year":"2000","journal-title":"Methods Find Exp Clin Pharmacol"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0043","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jconrel.2013.06.038","article-title":"High concentrations of drug in target tissues following local controlled release are utilized for both drug distribution and biologic effect:an example with epicardial inotropic drug delivery","volume":"171","author":"Maslov","year":"2013","journal-title":"J Control Release"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0044","doi-asserted-by":"crossref","first-page":"H289","DOI":"10.1152\/ajpheart.00579.2018","article-title":"Synergy between sacubitril and valsartan leads to hemodynamic, antifibrotic, and exercise tolerance benefits in rats with preexisting heart failure","volume":"316","author":"Maslov","year":"2019","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0045","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.cardfail.2018.10.006","article-title":"A novel paradigm for sacubitril\/valsartan: beta-endorphin elevation as a contributor to exercise tolerance improvement in rats with preexisting heart failure induced by pressure overload","volume":"24","author":"Maslov","year":"2018","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0046","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1136\/hrt.2004.042614","article-title":"Aortic regurgitation","volume":"92","author":"Maurer","year":"2006","journal-title":"Heart"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0047","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/ejhf.250","article-title":"Neprilysin inhibition to treat heart failure: a tale of science, serendipity, and second chances","volume":"17","author":"McMurray","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0048","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0049","series-title":"Cardiovascular medicine","first-page":"1811","article-title":"Arterial compliance","author":"McVeigh","year":"2007"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0050","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.ijcard.2004.12.020","article-title":"Effects of human atrial natriuretic peptide on cardiac function and hemodynamics in patients with high plasma BNP levels","volume":"104","author":"Nakajima","year":"2005","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0051","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S1388-9842(98)00003-8","article-title":"Placebo-controlled comparison of candoxatril, an orally active neutral endopeptidase inhibitor, and captopril in patients with chronic heart failure","volume":"1","author":"Northridge","year":"1999","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0052","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.jjcc.2014.12.020","article-title":"Effects of human atrial natriuretic peptide on myocardial performance and energetics in heart failure due to previous myocardial infarction","volume":"66","author":"Ozawa","year":"2015","journal-title":"J Cardiol"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0053","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1038\/nprot.2008.138","article-title":"Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats","volume":"3","author":"Pacher","year":"2008","journal-title":"Nat Protoc"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0054","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1161\/01.CIR.74.4.766","article-title":"Preservation of glomerular filtration rate in human heart failure by activation of the renin-angiotensin system","volume":"74","author":"Packer","year":"1986","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0055","series-title":"Kaplan's essentials of cardiac anesthesia, 2nd ed.","first-page":"62","article-title":"Cardiac Physiology","author":"Pagel","year":"2018"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0056","series-title":"Cardiovascular physiology, 10th ed.","first-page":"195","article-title":"Control of cardiac output: coupling of heart and blood vessels","author":"Pappano","year":"2013"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0057","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1093\/eurjhf\/hfp120","article-title":"A randomized, double-blind, placebo-controlled study to determine the effects of valsartan on exercise time in patients with symptomatic heart failure with preserved ejection fraction","volume":"11","author":"Parthasarathy","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0058","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1054\/jcaf.2003.17","article-title":"Left ventricular response to sustained volume overload from chronic aortic valve regurgitation in rats","volume":"9","author":"Plante","year":"2003","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0059","first-page":"241","article-title":"Reduction of regurgitation in aortic insufficiency by inhibition of the renin-angiotensin converting enzyme","volume":"23","author":"Reske","year":"1984","journal-title":"Nuklearmedizin"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0060","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/949624","article-title":"Transcriptional changes associated with long-term left ventricle volume overload in rats: impact on enzymes related to myocardial energy metabolism","author":"Roussel","year":"2015","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0061","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.HYP.0000164581.39811.bd","article-title":"Basal NO locally modulates human iliac artery function in vivo","volume":"46","author":"Schmitt","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0062","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.006617","article-title":"Angiotensin II receptor-neprilysin inhibitor sacubitril\/valsartan improves endothelial dysfunction in spontaneously hypertensive rats","volume":"6","author":"Seki","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0063","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.jchf.2016.05.002","article-title":"Efficacy of sacubitril\/valsartan relative to a prior decompensation: the PARADIGM-HF trial","volume":"4","author":"Solomon","year":"2016","journal-title":"JACC Heart Fail"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0064","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1161\/01.CIR.83.1.304","article-title":"Relation between maximum time-varying elastance pressure-volume areas and myocardial oxygen consumption in dogs","volume":"83","author":"Starling","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0065","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.cardfail.2017.12.010","article-title":"LCZ696 (sacubitril\/valsartan), an angiotensin-receptor neprilysin inhibitor, attenuates cardiac hypertrophy, fibrosis, and vasculopathy in a rat model of chronic kidney disease","volume":"24","author":"Suematsu","year":"2018","journal-title":"J Card Fail"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0066","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/ejhf.474","article-title":"LCZ696, an angiotensin receptor-neprilysin inhibitor, improves cardiac function with the attenuation of fibrosis in heart failure with reduced ejection fraction in streptozotocin-induced diabetic mice","volume":"18","author":"Suematsu","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0067","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1111\/jcmm.12551","article-title":"Novel mechanism of cardiac protection by valsartan: synergetic roles of TGF-beta1 and HIF-1alpha in Ang II-mediated fibrosis after myocardial infarction","volume":"19","author":"Sui","year":"2015","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0068","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1161\/01.HYP.32.2.273","article-title":"Early induction of transforming growth factor-beta via angiotensin II type 1 receptors contributes to cardiac fibrosis induced by long-term blockade of nitric oxide synthesis in rats","volume":"32","author":"Tomita","year":"1998","journal-title":"Hypertension"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0069","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.008268","article-title":"Combined angiotensin receptor-neprilysin inhibitors improve cardiac and vascular function via increased NO bioavailability in heart failure","volume":"7","author":"Trivedi","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0070","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0160-5402(89)90004-1","article-title":"A simple method for producing graded aortic insufficiencies in rats and subsequent development of cardiac hypertrophy","volume":"22","author":"Uematsu","year":"1989","journal-title":"J Pharmacol Methods"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0071","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1002\/prp2.336","article-title":"Prevention against renal damage in rats with subtotal nephrectomy by sacubitril\/valsartan (LCZ696), a dual-acting angiotensin receptor-neprilysin inhibitor","volume":"5","author":"Ushijima","year":"2017","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0072","first-page":"1465","article-title":"Effect of sinorphan, an endopeptidase inhibitor on severe congestive cardiac insufficiency","volume":"84","author":"Varin","year":"1991","journal-title":"Arch Mal Coeur Vaiss"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0073","doi-asserted-by":"crossref","first-page":"244","DOI":"10.3317\/jraas.2003.039","article-title":"Haemodynamic and pulse wave responses to intravenous infusions of angiotensin II during chronic telmisartan therapy in normal volunteers","volume":"4","author":"Vingerhoedt","year":"2003","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0074","first-page":"76","article-title":"Increased concentrations of atrial natriuretic peptide in the plasma and heart atrium of patients with aortic and mitral valve diseases compared to patients with coronary heart disease","volume":"76","author":"Wambach","year":"1987","journal-title":"Z Kardiol"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0075","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11517-008-0359-2","article-title":"The arterial Windkessel","volume":"47","author":"Westerhof","year":"2009","journal-title":"Med Biol Eng Comput"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0076","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1161\/hc0202.101970","article-title":"Nitric oxide regulates local arterial distensibility in vivo","volume":"105","author":"Wilkinson","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0077","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S0735-1097(02)02063-6","article-title":"Valsartan benefits left ventricular structure and function in heart failure: Val-HeFT echocardiographic study","volume":"40","author":"Wong","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0078","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/01.HYP.19.6.692","article-title":"In vivo metabolism of angiotensin I by neutral endopeptidase (EC 3.4.24.11) in spontaneously hypertensive rats","volume":"19","author":"Yamamoto","year":"1992","journal-title":"Hypertension"},{"key":"10.1016\/j.cardfail.2019.09.008_bib0079","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2147\/VHRM.S114784","article-title":"Profile of sacubitril\/valsartan in the treatment of heart failure: patient selection and perspectives","volume":"13","author":"Yandrapalli","year":"2017","journal-title":"Vasc Health Risk Manag"}],"container-title":["Journal of Cardiac Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916419304919?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1071916419304919?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T22:22:00Z","timestamp":1574374920000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1071916419304919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":79,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S1071916419304919"],"URL":"https:\/\/doi.org\/10.1016\/j.cardfail.2019.09.008","relation":{},"ISSN":["1071-9164"],"issn-type":[{"value":"1071-9164","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]}}}